Here you can download summaries of studies that have been published in recent years on sclerotherapy of varicose veins.

Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease      

Kreussler Studies
Summary of pivotal studies on sclerotherapy of varicose veins

Zhang J et al. Efficacy and safety of Aethoxysklerol (Polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).

Phlebology 2012;27(4):184-190

 

Rabe et al. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).

Phlebology 2010;25(3):124-31

Rabe et al. Efficacy and Safety of Great Saphenous Vein Sclerotherapy Using Standardised Polidocanol Foam (ESAF): A Randomised Controlled Multicentre Clinical Trial.

Eur J Vasc Endovasc Surg 2008;35(2):238-45

Guex et al. Immediate and Midterm Complications of Sclerotherapy: Report of a Prospective Multicenter Registry of 12,173 Sclerotherapy Sessions.

Dermatol Surg 2005;31(2):123-8

Guex et al. The French Polidocanol Study on Long-Term Side Effects: A Survey Covering 3,357 Patient Years.

Dermatol Surg 2010;36 Suppl 2:993-1003
Please note: Not all concentrations and indications are available in every country. Trade names may vary from country to country. Information on this website is based on German Summary of Product Characteristics.

Please refer to your national marketing authorization.